Target intelligence / Profile preview

Double-stranded DNA (5′-PuGATCPy-3′ sequence) (dsDNA (PuGATCPy))

Target
dsDNA (PuGATCPy)
Molecular classification
Other
01

Overview

Double-stranded DNA containing the 5′-PuGATCPy-3′ sequence (where Pu represents a purine and Py represents a pyrimidine) is a specific genomic motif that serves as a high-affinity binding site for certain anthracycline antibiotics, most notably nogalamycin and its semi-synthetic derivative menogaril (Searle et al., 1988, Biochemistry). This hexanucleotide sequence is characterized by its ability to accommodate the threading intercalation of these drugs, where the planar chromophore inserts between base pairs while bulky amino-sugar groups occupy both the major and minor grooves of the DNA helix (Williams et al., 1990, PNAS). Biologically, the formation of these stable DNA-drug complexes at PuGATCPy sites interferes with critical cellular processes, including DNA replication and RNA transcription, by physically blocking the progression of polymerase enzymes and inhibiting the activity of topoisomerases (PubChem, CID 119045). In the context of disease, this target is primarily relevant to oncology, as the disruption of DNA integrity and function leads to cell cycle arrest and apoptosis in rapidly proliferating cancer cells (National Cancer Institute). However, the therapeutic use of agents targeting these sequences is often limited by significant safety concerns, including myelosuppression and potential cardiotoxicity, which are common side effects of DNA-intercalating anthracyclines (StatPearls, Anthracyclines).

Other names
PuGATCPy DNA motifNogalamycin binding site5'-d(PuGATCPy)-3' sequenceHexanucleotide DNA intercalation site
02

Mechanism of action

DNA intercalation and simultaneous major/minor groove binding, leading to inhibition of DNA/RNA polymerase progression and topoisomerase activity.

03

Biological functions

Other
04

Disease associations

Cancer
05

Safety considerations

MyelosuppressionCardiotoxicityGenotoxicitySecondary malignanciesLack of absolute sequence specificity
06

Interacting drugs

Nogalamycin

1 more in the full profile.

07

Biomarkers

Gamma-H2AX (DNA damage marker)Topoisomerase II expression levels

Beyond the preview

Go deeper on Double-stranded DNA (5′-PuGATCPy-3′ sequence) (dsDNA (PuGATCPy)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Double-stranded DNA (5′-PuGATCPy-3′ sequence) (dsDNA (PuGATCPy)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call